financetom
Business
financetom
/
Business
/
Serve Robotics Shares Skid: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Serve Robotics Shares Skid: What's Going On?
Nov 13, 2025 11:20 AM

Serve Robotics Inc ( SERV ) shares are trading lower on Thursday. The company disclosed its financial results for the third quarter.

SERV is underperforming relative to peers. Get the market research here.

What To Know: Serve Robotics ( SERV ) reported quarterly losses of 40 cents per share, versus the analyst consensus estimate for losses of 33 cents per share.

The company’s quarterly sales of $687,000 were also lower than analyst estimates of $691,167, per Benzinga Pro. The number compares to sales of $221,555 during the same period last year, representing a 210.08% increase.

“The relentless execution of our scale plan continues to drive consistent revenue growth,” said Brian Read, CFO of Serve. “We will continue to invest in key capabilities that strengthen our industry-leading autonomy and robotics platform, including integration of our recent Phantom Auto and Vayu acquisitions, to expand our increasingly diverse revenue stack.”

During the quarter, Serve Robotics ( SERV ) deployed more than 1,000 robots. When compared to the third quarter of 2024, daily supply hours increased by more than 713%.

In order to expand its nationwide reach, the company started operations in the Chicago market and signed a new, multi-year strategic partnership with DoorDash Inc ( DASH ) to roll out deliveries throughout the U.S. Currently, Serve Robotics ( SERV ) serves three million people in the United States and more than 3,600 restaurants.

The company noted that it raised $100 million through a registered direct share offering after finishing the quarter with $210 million in total liquidity.

Serve Robotics ( SERV ) anticipates that revenue for fiscal 2025 will exceed $2.5 million, versus estimates of $4.14 million. Despite issuing disappointing guidance for 2025, the company said it expects a roughly 10-fold increase in revenue in 2026 based on preliminary projections.

SERV Price Action: Serve Robotics ( SERV ) shares were down 10.36% at $9.39 at the time of publication on Thursday, according to Benzinga Pro.

Read Next:

Cisco, Firefly Aerospace, Pan American Silver, Serve Robotics And Circle: Why These 5 Stocks Are On Investors’ Radars Today

Image: Walter Cicchetti/Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Turning Vision Into Value: Cie Portfolio Win as Nativo Is Acquired for $120M
Turning Vision Into Value: Cie Portfolio Win as Nativo Is Acquired for $120M
Nov 13, 2025
IRVINE, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Cie, a venture studio, announced today that its portfolio company Nativo, a leading advertising technology provider, has entered into a definitive agreement to be acquired by Life360 ( LIF ) . The transaction, valued at approximately $120 million in cash and stock, marks another successful outcome of Cie’s venture studio model. Nativo joins...
Intuitive Surgical Insider Sold Shares Worth $435,000, According to a Recent SEC Filing
Intuitive Surgical Insider Sold Shares Worth $435,000, According to a Recent SEC Filing
Nov 13, 2025
01:58 PM EST, 11/13/2025 (MT Newswires) -- Craig H Barratt, Director, on November 12, 2025, sold 750 shares in Intuitive Surgical ( ISRG ) for $435,000. Following the Form 4 filing with the SEC, Barratt has control over a total of 27,198 common shares of the company, with 27,198 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1035267/000127762025000008/xslF345X05/edgardoc.xml Price: 568.86, Change: -3.60, Percent Change:...
Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial
Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial
Nov 13, 2025
Gilead Sciences Inc ( GILD ). on Thursday shared topline results from the Phase 3 ARTISTRY-1 trial. The open-label trial evaluated the treatment responses of HIV patients who are virologically suppressed switching from a multi-tablet regimen to an investigational single-tablet regimen of bictegravir 75 mg/lenacapavir 50 mg (BIC/LEN). • GILD shares are testing new highs. Check the market position here....
Serve Robotics Shares Skid: What's Going On?
Serve Robotics Shares Skid: What's Going On?
Nov 13, 2025
Serve Robotics Inc ( SERV ) shares are trading lower on Thursday. The company disclosed its financial results for the third quarter. SERV is underperforming relative to peers. Get the market research here. What To Know: Serve Robotics ( SERV ) reported quarterly losses of 40 cents per share, versus the analyst consensus estimate for losses of 33 cents per share....
Copyright 2023-2026 - www.financetom.com All Rights Reserved